Recent developments include the Q1 2026 earnings release and conference call, highlighting sales growth driven by pricing and volume, alongside a profit retreat. The company continues to advance its Strategic Growth and Productivity Program with associated costs and anticipated savings.

• Colgate-Palmolive reported Q1 2026 net sales of $5.324 billion and net income attributable to the company of $646 million, with basic EPS of $0.81 and diluted EPS of $0.80 [N1][N2][N3][N4][N5][N6][S2].
• The company highlighted pricing and volume growth as key drivers of sales performance in Q1 2026 [N2][N3].
• Profit retreated in Q1 2026 compared to the prior year quarter, reflecting cost pressures despite sales growth [N6].
• The Strategic Growth and Productivity Program incurred pre-tax costs of $176 million in Q1 2026, with ongoing initiatives to optimize operations and support the 2030 strategy [S2].
• The company realigned its geographic segments effective Q1 2026, combining Europe and Africa/Eurasia into a new EMEA segment and reclassifying Russia and Belarus into Asia Pacific [S2].

The company demonstrates resilience through geographic diversification and a broad product portfolio spanning oral care, personal care, home care, and pet nutrition. Its Strategic Growth and Productivity Program aims to enhance operational efficiency and support long-term growth. Recent sales growth driven by pricing and volume improvements indicates effective market execution. Strong liquidity and cash flow generation support investments in growth and shareholder returns.

Profit retreat in Q1 2026 despite sales growth suggests margin pressures or cost challenges. The Strategic Growth and Productivity Program involves significant pre-tax charges, which may impact near-term profitability. Exposure to emerging markets introduces geopolitical and economic risks. Competitive pressures in consumer goods markets and potential supply chain disruptions could affect performance. The company's relatively low current ratio near 1.0 indicates limited short-term liquidity cushion.

Colgate-Palmolive's moat is supported by its strong global brand portfolio, extensive distribution network across more than 200 countries, and diversified geographic exposure that reduces risk concentration. Its scale in manufacturing, sourcing, and distribution, combined with ongoing strategic initiatives to optimize operations and drive growth, contribute to competitive advantages. The company's presence in essential consumer categories and its ability to leverage innovation and brand equity underpin its market position.

• Profitability Pressure: Net income declined in Q1 2026 compared to the prior year quarter, indicating potential margin compression or increased costs.
• Implementation Costs: The Strategic Growth and Productivity Program involves substantial pre-tax charges that may affect near-term financial results.
• Geopolitical and Market Risks: Significant sales exposure to emerging markets introduces risks related to economic volatility, regulatory changes, and geopolitical tensions.
• Competitive Environment: The consumer products industry is highly competitive, requiring continuous innovation and marketing investment to maintain market share.
• Liquidity Constraints: Current ratio near 1.02 suggests limited buffer for short-term liabilities, which could pose liquidity risks under adverse conditions.

• Colgate-Palmolive Company operates globally in more than 200 countries and territories, with approximately two-thirds of net sales generated outside the United States and about 45% from emerging markets including Latin America, Asia (excluding Japan), Africa, the Middle East, and Eastern and Central Europe [S2].
• The company operates in two main product segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment is managed geographically in four reportable operating segments: North America, Latin America, EMEA (Europe, Middle East & Africa), and Asia Pacific [S2].
• In Q1 2026, the company realigned its reportable operating segments combining Europe and Africa/Eurasia (excluding Russia and Belarus) and the skin health business into a new EMEA segment, and reclassified Russia and Belarus into the Asia Pacific segment. Historical segment data has been recast accordingly [S2].
• Colgate-Palmolive sells primarily to retailers, wholesalers, distributors, dentists, and in some regions, skin health professionals. Hill's Pet Nutrition products are sold principally through authorized pet supply retailers, veterinarians, and eCommerce retailers, with some direct-to-consumer sales [S2].
• The company has a Strategic Growth and Productivity Program aimed at optimizing operations and driving growth, with an expansion approved in April 2026. The program is expected to incur cumulative pre-tax charges between $350 million and $550 million, with annualized pre-tax savings estimated between $200 million and $300 million once fully implemented [S2].
• Q1 2026 financial highlights include net sales of $5.324 billion, gross profit of $3.226 billion, operating profit of $964 million, and net income attributable to Colgate-Palmolive Company of $646 million. Basic earnings per share were $0.81 and diluted EPS was $0.80 for the quarter ended March 31, 2026 [S2].
• The company reported cash and cash equivalents of $1.335 billion and current assets of $6.082 billion against current liabilities of $5.934 billion as of March 31, 2026, resulting in a current ratio of approximately 1.02 and a cash ratio of 0.24 [S2].
• Colgate-Palmolive's balance sheet as of March 31, 2026, shows total assets of approximately $16.61 billion and total liabilities of about $16.12 billion, with shareholders' equity of $145 million and total equity including noncontrolling interests of $486 million [S2].
• The company incurred pre-tax costs of $176 million (after-tax $138 million) related to the Strategic Growth and Productivity Program in Q1 2026 [S2].
• Colgate-Palmolive's Q1 2026 net income declined compared to the prior year quarter ($646 million vs. $690 million), reflecting some profit retreat despite sales growth [N6][S2].
• The company emphasizes strong free cash flow generation, cost reduction initiatives, and capital allocation focused on growth and profitability [S2].
• Colgate-Palmolive monitors key performance indicators including net sales, organic sales growth, gross profit margin, operating profit, net income, and earnings per share, both on GAAP and non-GAAP bases, as well as market share and household penetration data [S2].
• The company has a global manufacturing, sourcing, warehousing, and distribution network supporting its operations worldwide [S2].
• Colgate-Palmolive's recent Q1 2026 earnings call and reports highlight pricing and volume growth as drivers of sales performance [N1][N2][N3][N4][N5].